Neuroone Medical Technologies Corp
NASDAQ:NMTC

Watchlist Manager
Neuroone Medical Technologies Corp Logo
Neuroone Medical Technologies Corp
NASDAQ:NMTC
Watchlist
Price: 0.712 USD -5% Market Closed
Market Cap: 35.5m USD

Wall Street
Price Targets

NMTC Price Targets Summary
Neuroone Medical Technologies Corp

Wall Street analysts forecast NMTC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NMTC is 1.479 USD with a low forecast of 1.465 USD and a high forecast of 1.523 USD.

Lowest
Price Target
1.465 USD
106% Upside
Average
Price Target
1.479 USD
108% Upside
Highest
Price Target
1.523 USD
114% Upside
Neuroone Medical Technologies Corp Competitors:
Price Targets
AFX
Carl Zeiss Meditec AG
29% Upside
ATEC
Alphatec Holdings Inc
70% Upside
041830
InBody Co Ltd
49% Upside
ATRC
AtriCure Inc
67% Upside
SRT
Sartorius AG
66% Upside
7716
Nakanishi Inc
55% Upside
NVST
Envista Holdings Corp
3% Downside
COH
Cochlear Ltd
2% Downside

Revenue
Forecast

Revenue Estimate
Neuroone Medical Technologies Corp

The compound annual growth rate of Neuroone Medical Technologies Corp's revenue for the next 3 years is 68%.

N/A
Past Growth
68%
Estimated Growth
Estimates Accuracy
-25%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Neuroone Medical Technologies Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

Net Income Estimate
Neuroone Medical Technologies Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-68%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NMTC's stock price target?
Price Target
1.479 USD

According to Wall Street analysts, the average 1-year price target for NMTC is 1.479 USD with a low forecast of 1.465 USD and a high forecast of 1.523 USD.

What is Neuroone Medical Technologies Corp's Revenue forecast?
Projected CAGR
68%

The compound annual growth rate of Neuroone Medical Technologies Corp's revenue for the next 3 years is 68%.

Back to Top